BioMarin Pharmaceutical I... (BMRN)
NASDAQ: BMRN
· Real-Time Price · USD
55.43
-0.14 (-0.25%)
At close: Oct 03, 2025, 3:59 PM
55.56
0.23%
After-hours: Oct 03, 2025, 07:47 PM EDT
-0.25% (1D)
| Bid | 55.43 |
| Market Cap | 10.64B |
| Revenue (ttm) | 3.06B |
| Net Income (ttm) | 657.24M |
| EPS (ttm) | 3.39 |
| PE Ratio (ttm) | 16.35 |
| Forward PE | 12.16 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 58.4 |
| Volume | 2,058,281 |
| Avg. Volume (20D) | 2,349,079.7 |
| Open | 55.42 |
| Previous Close | 55.57 |
| Day's Range | 55.01 - 56.00 |
| 52-Week Range | 52.48 - 73.51 |
| Beta | 0.33 |
| Ex-Dividend Date | n/a |
About BMRN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BMRN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BMRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBioMarin Pharmaceutical Inc. is scheduled to release its earnings on
Oct 28, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+2.69%
BioMarin Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
2 months ago
+3.73%
BioMarin Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 guidance.
